Last viewed:
PMD
Prices are updated after-hours
PMD
|
$2.56
820
|
Health Services
(0.0% 1d)
(-13.8% 1m)
(-52.1% 1y)
(0.0% 2d)
(-3.4% 3d)
(-9.2% 7d)
(-87.38%
volume)
Earnings Calendar:
Market Cap: $ 14,862,364
http://www.psychemedics.com
Sec
Filling
|
Patents
| 204 employees
Psychemedics Corp. engages in the provision of drug testing services through the analysis of hair samples. It specializes in a five panel drug testing process for cocaine, opioids, Phenyclidine, amphetamines, and marijuana. It offers workplace, school, and personal drug testing services. The company was founded by Werner Baumgartner and Annette Baumgartner on September 24, 1986 and is headquartered in Acton, MA.
opioid
add to watch list
Paper trade
email alert is off
Press-releases
Global Clinical In-Vitro Diagnostic Medical Laboratory Service Report 2024: Alternative Medicine Creates Opportunities, Esoteric Testing Moving Mainstream, Genetic Based Testing Creates New Department
Published: 2024-03-29
(Crawled : 02:00)
- prnewswire.com
PMD
|
$2.56
820
|
Health Services
| Email alert
Add to watchlist
report
service
diagnostic
genetic
global
in-vitro
medical
alternative
Psychemedics Corporation Reports 2023 Financial Results
Published: 2024-03-28
(Crawled : 12:00)
- globenewswire.com
PMD
|
$2.56
820
|
Health Services
| -16.07%
| O: -1.64%
H: 0.0%
C: -2.33%
corporation
financial
results
Psychemedics Recognized as a Top 10 Employee Health Testing Services Provider
Published: 2024-03-21
(Crawled : 13:00)
- globenewswire.com
PMD
|
$2.56
820
|
Health Services
| -12.93%
| O: 0.0%
H: 4.08%
C: 2.04%
services
health
employee
Psychemedics Corporation Announces Relocation of Headquarters to Dallas, Texas
Published: 2024-01-02
(Crawled : 17:00)
- globenewswire.com
PMD
|
$2.56
820
|
Health Services
| -13.51%
| O: -1.35%
H: 17.12%
C: 16.1%
corporation
Psychemedics Corporation Appoints Daniella Mehalik as VP - Finance
Published: 2023-11-27
(Crawled : 14:00)
- globenewswire.com
PMD
|
$2.56
820
|
Health Services
| 15.84%
| O: 3.17%
H: 3.95%
C: 0.88%
NBSE
|
$0.402
6.3K
|
Health Technology
| -40.51%
| O: -2.56%
H: 2.57%
C: -0.99%
corporation
Psychemedics Corporation Reports Third Quarter 2023 Financial Results
Published: 2023-11-09
(Crawled : 22:00)
- globenewswire.com
PMD
|
$2.56
820
|
Health Services
| 5.35%
| O: 0.82%
H: 0.0%
C: -4.08%
corporation
financial
results
Unveiling the Future of Drug Testing: Psychemedics Introduces Advanced 5-Panel Drug Screen
Published: 2023-10-27
(Crawled : 15:00)
- globenewswire.com
PMD
|
$2.56
820
|
Health Services
| 8.47%
| O: 2.12%
H: 2.07%
C: 1.66%
drug
Unveiling the Future of Drug Testing: Psychemedics Introduces Advanced 5-Panel Drug ScreenPsychemedics’ FDA-cleared alternative 5-panel drug screen replaces marijuana with fentanyl.
Published: 2023-10-27
(Crawled : 19:00)
- biospace.com/
PMD
|
$2.56
820
|
Health Services
| 8.47%
| O: 2.12%
H: 2.07%
C: 1.66%
drug
alternative
Psychemedics Corporation Appoints Shannon Shoemaker as Chief Revenue Officer
Published: 2023-09-21
(Crawled : 21:00)
- globenewswire.com
PMD
|
$2.56
820
|
Health Services
| -30.05%
| O: 3.01%
H: 0.0%
C: -2.38%
corporation
Psychemedics Corporation Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Published: 2023-08-18
(Crawled : 18:00)
- globenewswire.com
PMD
|
$2.56
820
|
Health Services
| Email alert
Add to watchlist
nasdaq
corporation
grants
See all
Last 15 days Sec forms
File Id
Form
Published Date
Transaction Date
Direction
Code
Amount Transacted
Owned Amount
0001062993-23-018458
4
2023-09-25
2023-09-21
Buy
A
80000
80000
0001062993-23-018458
4
2023-09-25
2023-09-21
Buy
A
40000
40000